Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
Authors
Keywords
-
Journal
Journal of Fungi
Volume 6, Issue 2, Pages 90
Publisher
MDPI AG
Online
2020-06-22
DOI
10.3390/jof6020090
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy
- (2019) E Furfaro et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inter-laboratory analysis of Isavuconazole plasma concentration assays among European laboratories
- (2019) Federico Pea et al. THERAPEUTIC DRUG MONITORING
- Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology
- (2019) Oliver A. Cornely et al. MYCOSES
- Influence of Sustained Low-Efficiency Dialysis (SLED) treatment on Isavuconazole plasma levels in critically ill patients
- (2019) Tobias Lahmer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole Diffusion in Infected Human Brain
- (2019) Claire Rouzaud et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Prophylaxis with Posaconazole Delayed-Release Tablet and Oral Suspension in a Real-Life Setting: Plasma Levels, Efficacy, and Tolerability
- (2018) David Lenczuk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials
- (2018) David Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OUP accepted manuscript
- (2018) MEDICAL MYCOLOGY
- Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
- (2018) Jeffrey D Jenks et al. Drug Design Development and Therapy
- Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study
- (2018) Alexander F A D Schauwvlieghe et al. Lancet Respiratory Medicine
- Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases
- (2018) Thomas Kaindl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)
- (2016) Laura L. Kovanda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Isavuconazole: a role for the newest broad-spectrum triazole
- (2016) Monica A Slavin et al. LANCET
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
- (2012) Stijn I. Blot et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies
- (2012) M. Hoenigl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation
- (2009) I. Spriet et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
- (2008) Brahm H. Segal et al. CLINICAL INFECTIOUS DISEASES
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search